Patent details

EP1446122 Title: USE OF FLIBANSERIN IN THE TREATMENT OF SEXUAL DESIRE DISORDERS

Basic Information

Publication number:
EP1446122
PCT Application Number:
PCT/EP/2002/011103
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP028018802
PCT Publication Number:
WO/2003/035072
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF FLIBANSERIN IN THE TREATMENT OF SEXUAL DESIRE DISORDERS
French Title of Invention:
UTILISATION DE LA FLIBANSERINE DANS LE TRAITEMENT DE TROUBLES DU DESIR SEXUEL
German Title of Invention:
VERWENDUNG VON FLIBANSERIN BEI DER BEHANDUNG VON STÖRUNGEN DES SEXUELLEN VERLANGENS
SPC Number:

Dates

Filing date:
04/10/2002
Grant date:
31/05/2006
EP Publication Date:
31/05/2006
PCT Publication Date:
01/05/2003
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
18/08/2004
EP B1 Publication Date:
31/05/2006
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
04/10/2014
Expiration date:
04/10/2022
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
04/10/2002
 
 

Name:
Boehringer Ingelheim Pharma GmbH & Co.KG
Address:
Binger Strasse 173, 55216 Ingelheim am Rhein, Germany (DE)

Inventor

1

Name:
EVANS Kenneth, Robert
Address:
Canada (CA)

2

Name:
BORSINI Franco
Address:
Germany (DE)

Priority

Priority Number:
01125020
Priority Date:
20/10/2001
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
A61K 31/496;
Filing date Document type Number of pages